This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Background New highly effective medications are available to treat the hepatitis C virus
(HCV). However, little is known about HCV treatment knowledge and readiness among …

Background New treatments for hepatitis C (HCV) infection hold great promise for cure, but
numerous challenges to diagnosing, establishing care, and receiving therapy exist. There …

Background. The effectiveness of interferon-free direct-acting antivirals (DAA) in treating
chronic hepatitis C virus (HCV) is limited by low screening and treatment rates, particularly …

Abstract Background Hepatitis C virus (HCV) is highly prevalent among homeless persons,
yet barriers continue to impede HCV testing and treatment in this population. We studied the …

Summary Background Although treatment for Hepatitis C Virus (HCV) is effective, individuals
face access barriers. The utility of mobile health clinics (MHC), effective mechanisms for …

AIM To describe racial/ethnic differences in treatment and survival among liver cancer
patients in a population-based cancer registry. METHODS Invasive cases of primary …

Hepatitis C virus (HCV) prevalence is high among people experiencing homelessness, but
barriers to scaling up HCV testing and treatment persist. We aimed to implement onsite HCV …

Background This study uses machine learning techniques to identify sociodemographic and
clinical predictors of progression through the hepatitis C (HCV) cascade of care for patients …

Chronic hepatitis C (CHC) disproportionately affects racial minorities in the United States
(US). Although prior studies have reported lower treatment rates in Blacks than in …